Literature DB >> 11596022

Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma.

M Kimura1, Y Tomita, T Imai, T Saito, A Katagiri, Y Ohara-Mikami, T Matsudo, K Takahashi.   

Abstract

BACKGROUND: Evidence of systemic inflammation, i.e., elevation of serum C-reactive protein, interleukin-6, and/or the erythrocyte sedimentation rate, is correlated to poorer prognosis of patients with renal cell carcinoma (RCC). Serum amyloid A (SAA) has been recognized mainly as acute-phase reactant.
METHODS: Serum SAA from 72 patients with RCC were examined. Thirty-eight of 72 patients with RCC had elevated SAA compared with 17 healthy donors.
RESULTS: The disease specific survival rate was significantly lower in the elevated SAA group, and SAA level was shown to be an independent prognostic factor by univariate and multivariate analysis.
CONCLUSIONS: Evaluation of serum SM level in RCC patients may be a useful prognostic indicator. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596022     DOI: 10.1002/1097-0142(20011015)92:8<2072::aid-cncr1547>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

Review 1.  Basic research in kidney cancer.

Authors:  Egbert Oosterwijk; W Kimryn Rathmell; Kerstin Junker; A Rose Brannon; Frédéric Pouliot; David S Finley; Peter F A Mulders; Ziya Kirkali; Hirotsugo Uemura; Arie Belldegrun
Journal:  Eur Urol       Date:  2011-07-05       Impact factor: 20.096

Review 2.  Biomarkers for the development of cancer vaccines: current status.

Authors:  John Copier; Mike Whelan; Angus Dalgleish
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  A BALB/c murine lung alveolar carcinoma used to establish a surgical spontaneous metastasis model.

Authors:  Michael McLean; Howard L Wallace; Atima Sharma; Hank C Hill; Michael S Sabel; Nejat K Egilmez
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Proteomic analysis of blood level of proteins before and after operation in patients with esophageal squamous cell carcinoma at high-incidence area in Henan Province.

Authors:  Ji-Ye An; Zong-Min Fan; Ze-Hao Zhuang; Yan-Ru Qin; Shan-Shan Gao; Ji-Lin Li; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

5.  Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer.

Authors:  S L Wood; M Rogers; D A Cairns; A Paul; D Thompson; N S Vasudev; P J Selby; R E Banks
Journal:  Br J Cancer       Date:  2010-06-08       Impact factor: 7.640

6.  Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.

Authors:  John A Sandoval; Katharyn E Turner; Derek J Hoelz; Frederick J Rescorla; Robert J Hickey; Linda H Malkas
Journal:  J Surg Res       Date:  2007-08-29       Impact factor: 2.192

7.  Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.

Authors:  Brandon L Pierce; Rachel Ballard-Barbash; Leslie Bernstein; Richard N Baumgartner; Marian L Neuhouser; Mark H Wener; Kathy B Baumgartner; Frank D Gilliland; Bess E Sorensen; Anne McTiernan; Cornelia M Ulrich
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

Review 8.  Serum amyloid A: an acute-phase protein involved in tumour pathogenesis.

Authors:  E Malle; S Sodin-Semrl; A Kovacevic
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

9.  Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines.

Authors:  Alenka Kovacevic; Astrid Hammer; Elke Stadelmeyer; Werner Windischhofer; Monika Sundl; Alpana Ray; Natascha Schweighofer; Gerald Friedl; Reinhard Windhager; Wolfgang Sattler; Ernst Malle
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

10.  Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Jun-Ye Wang; Yu-Zhen Zheng; Juan Yang; Yue-Hao Lin; Shu-Qin Dai; Ge Zhang; Wan-Li Liu
Journal:  BMC Cancer       Date:  2012-08-23       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.